Gocke Elmar, Wall Michael
F. Hoffmann-La Roche Ltd., Nonclinical Safety, Basel, Switzerland.
Toxicol Lett. 2009 Nov 12;190(3):298-302. doi: 10.1016/j.toxlet.2009.03.008. Epub 2009 Mar 21.
EMS induced micronuclei and lacZ mutations in in vivo studies in mice with a clearly sublinear dose dependency. As reported elsewhere in this issue, NOEL dose values of between 25 mg/kg/day and 80 mg/kg/day were observed for the different endpoints and tissues analysed. Here we show that statistical assessment of the data provides solid support that the induction of mutagenic and clastogenic effects after in vivo treatment with the directly DNA damaging mutagen EMS adheres to a thresholded dose response relation. These data corroborate similar evidence obtained in in vitro studies. We conclude that cells are fully capable of repairing large amounts of DNA ethylations induced by EMS without experiencing elevated mutation frequencies. The stochastic, linear risk assessment model generally employed for DNA damaging genotoxins can therefore be refuted for EMS. While presently this conclusion cannot be generalized to other genotoxins a change of paradigm appears to be indicated at least for alkylating agents inducing a comparable type and spectrum of DNA lesions as EMS.
在小鼠体内研究中,EMS诱导了微核和lacZ突变,且具有明显的亚线性剂量依赖性。正如本期其他地方所报道的,对于所分析的不同终点和组织,观察到的无观察到不良作用水平(NOEL)剂量值在25毫克/千克/天至80毫克/千克/天之间。在此我们表明,对数据的统计评估提供了有力支持,即在用直接损伤DNA的诱变剂EMS进行体内处理后,诱变和断裂效应的诱导遵循阈值剂量反应关系。这些数据证实了在体外研究中获得的类似证据。我们得出结论,细胞完全有能力修复由EMS诱导的大量DNA甲基化,而不会出现突变频率升高的情况。因此,通常用于DNA损伤性基因毒素的随机线性风险评估模型不适用于EMS。虽然目前这一结论不能推广到其他基因毒素,但至少对于诱导与EMS具有可比类型和范围的DNA损伤的烷基化剂而言,似乎表明需要改变范式。